Table 1 |
||||
|
Patients characteristics |
||||
|
All patients (n = 79) |
AF recurrence (n = 47) |
Sinus rhythm (n = 32) |
P value |
|
|
|
||||
|
Duration of AF |
6.3 ± 9.3 |
8.0 ± 11.5 |
3.8 ± 3.0 |
<0.05 |
|
|
||||
|
Age |
62 ± 12 |
61 ± 14 |
64 ± 10 |
0.38 |
|
|
||||
|
Sex |
53 (67.1%) |
35 (74.5%) |
18 (56.3%) |
0.14 |
|
|
||||
|
Ishemic heart disease |
9 (11.4%) |
4 (8.5%) |
5 (15.6%) |
0.27 |
|
|
||||
|
Arterial hypertension |
58 (73.4%) |
36 (76.6%) |
22 (68.8%) |
0.45 |
|
|
||||
|
Diabetes |
3 (3.8%) |
0 |
3 (9.4%) |
0.06 |
|
|
||||
|
Treatment |
||||
|
|
||||
|
- Amiodarone |
60 (75.9%) |
32 (68.1%) |
28 (87.5%) |
0.06 |
|
|
||||
|
- Propafenone |
19 (24.1%) |
13 (27.7%) |
6 (18.8%) |
0.43 |
|
|
||||
|
- Beta blocker |
23 (29.1%) |
17 (36.2%) |
6 (18.8%) |
0.13 |
|
|
||||
|
-Angiotensin receptor blocker |
5 (6.3%) |
3 (6.4%) |
2 (6.3%) |
1.0 |
|
|
||||
|
- ACE inhibitor |
51 (64.4%) |
32 (68.1%) |
19 (59.4%) |
0.48 |
|
|
||||
|
- Statin |
20 (25.3%) |
9 (19.1%) |
11 (34.4%) |
0.19 |
|
|
||||
|
Cholesterol levels (mmol/L) |
5.1 ± 0.9 |
5.3 ± 1.1 |
4.9 ± 0.6 |
0.22 |
|
|
||||
|
CRP (mg/L) |
5.6 ± 7.4 |
5.1 ± 6.6 |
6.2 ± 8.6 |
0.61 |
|
|
||||
|
Lp(a) (g/L) |
0.21 ± 0.24 |
0.22 ± 0.23 |
0.19 ± 0.25 |
0.61 |
|
|
||||
|
Ejection fraction (%) |
51 ± 8 |
52 ± 8 |
50 ± 10 |
0.47 |
|
|
||||
|
Mitral regurgitation (stage 2 or higher) |
14 (17.7%) |
11 (23.4%) |
3 (9.4%) |
0.14 |
|
|
||||
|
Left atrium dimension |
5.2 ± 0.8 |
5.4 ± 0.7 |
5.1 ± 1.0 |
0.20 |
|
|
||||
|
Naji and Sabovic Journal of Negative Results in BioMedicine 2011 10:15 doi:10.1186/1477-5751-10-15 |
||||
